Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001010225 | SCV001170388 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-03-21 | criteria provided, single submitter | clinical testing | The c.1188dupT pathogenic mutation, located in coding exon 8 of the BRIP1 gene, results from a duplication of T at nucleotide position 1188, causing a translational frameshift with a predicted alternate stop codon (p.N397*). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Ai |
RCV002223965 | SCV002502906 | likely pathogenic | not provided | 2022-03-08 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003336228 | SCV004044524 | pathogenic | Familial cancer of breast | 2023-06-01 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |
Baylor Genetics | RCV003336228 | SCV004211313 | likely pathogenic | Familial cancer of breast | 2023-01-04 | criteria provided, single submitter | clinical testing |